EU Stocks

ALEUP.PA stock plunges 32% as Europlasma faces deep losses on EURONEXT

Key Points

ALEUP.PA stock crashed 32.14% to €0.0076 on EURONEXT amid panic selling.

Europlasma reports negative earnings of -€88.61 per share with severe operating losses.

Trading volume surged to 70 million shares, 2.6x average, signaling capitulation.

Company faces negative margins, negative cash flow, and deep liquidity stress.

Be the first to rate this article

ALEUP.PA stock crashed 32.14% to €0.0076 on May 4, 2026, marking another brutal session for Europlasma S.A. on EURONEXT. The French waste management and plasma technology company continues its downward spiral, with shares trading near historic lows. The stock has lost 99.98% over the past year, reflecting severe operational and financial distress. Trading volume surged to 70.1 million shares, more than double the average, signaling panic selling among investors. Meyka AI’s analysis reveals a company in crisis, with negative earnings per share of -88.61 and deteriorating fundamentals across all key metrics.

ALEUP.PA Stock Performance and Market Sentiment

Europlasma’s ALEUP.PA stock has become one of EURONEXT’s most distressed securities. The €0.0076 closing price represents a catastrophic decline from the €38.25 year-high, wiping out nearly all shareholder value.

Trading activity exploded today with 70.1 million shares changing hands, compared to the 27 million daily average. This 2.6x volume surge indicates forced liquidations and panic exits. The stock opened at €0.008 and traded between €0.0074 and €0.0088, showing extreme volatility typical of penny stocks. Over five days, ALEUP.PA has fallen 30.91%, while the one-month decline stands at 49.33%. The year-to-date loss reaches 96.71%, making this one of Europe’s worst-performing equities.

Financial Deterioration and Meyka AI Rating

Meyka AI rates ALEUP.PA with a grade of B (score: 62.8), suggesting a HOLD recommendation despite the stock’s distressed state. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. However, the underlying fundamentals paint a darker picture.

Earnings per share stand at -88.61, meaning the company loses money on every share outstanding. The company reported 2.59 million shares outstanding with a market cap of just €19,707. Revenue per share reached €215.38, but net income per share plummeted to -160.20, indicating massive operational losses. Free cash flow per share is -95.63, showing the company burns cash rapidly. These grades are not guaranteed and we are not financial advisors.

Waste Management Sector Context and Operational Challenges

Europlasma operates in the Industrials sector, specifically waste management and plasma torch technology. The company develops plasma solutions for hazardous waste, renewable energy from biomass, and asbestos treatment services. Founded in 1992 and based in Pessac, France, Europlasma employs 1,840 people.

The company’s operational metrics reveal severe stress. Operating profit margin sits at -47.22%, meaning operations lose nearly half of every revenue euro. Net profit margin is -74.38%, indicating massive bottom-line losses. Return on assets is -52.11%, while return on equity is just 3.03%. The current ratio of 0.80 signals liquidity concerns, as current liabilities exceed current assets. Working capital is deeply negative at -€13.48 million. Track ALEUP.PA on Meyka for real-time updates on this distressed security.

Technical Indicators and Forecast Outlook

Technical analysis reveals extreme weakness across all momentum indicators. The Relative Strength Index (RSI) stands at 37.98, indicating oversold conditions but with no sign of recovery. The Stochastic oscillator reads 2.47, near its lowest extreme. Williams %R is -96.94, the most bearish reading possible, suggesting capitulation selling.

Meyka AI’s forecast model projects a monthly price target of €0.11 and quarterly target of €0.37, implying potential upside from current levels. However, forecasts are model-based projections and not guarantees. The stock’s extreme volatility and negative fundamentals make price predictions highly unreliable. The company faces an earnings announcement on October 29, 2025, which could provide clarity on turnaround prospects or confirm further deterioration.

Final Thoughts

ALEUP.PA stock’s 32% crash reflects Europlasma S.A.’s severe financial crisis. With negative earnings, massive operating losses, and deteriorating cash flow, the company faces an existential challenge. The stock has lost nearly all value over twelve months, and today’s volume surge suggests capitulation among remaining shareholders. While Meyka AI assigns a HOLD rating based on technical factors, the fundamental reality is grim: negative margins, negative returns on assets, and negative free cash flow indicate a company burning through capital. Investors should recognize ALEUP.PA as a highly speculative, distressed security suitable only for those with extreme risk tolerance. The Octo…

FAQs

Why did ALEUP.PA stock fall 32% today?

ALEUP.PA crashed due to severe financial distress: negative earnings of €88.61 per share, massive operating losses, and negative free cash flow. Trading volume surged to 70 million shares, indicating panic liquidations.

What is Europlasma S.A.’s business model?

Europlasma develops plasma torch systems for industrial waste treatment, hazardous waste management, and renewable energy from biomass. The French company, founded in 1992, employs 1,840 people and provides asbestos neutralization services.

Is ALEUP.PA stock a buy at these levels?

ALEUP.PA is extremely high-risk due to negative margins, negative cash flow, and liquidity concerns. Rated HOLD, fundamentals suggest severe distress. Only extreme risk-tolerance investors should consider exposure.

What does Meyka AI’s B grade mean for ALEUP.PA?

Meyka AI’s B grade (62.8 score) suggests HOLD based on sector benchmarks. However, underlying financials remain deeply negative. Investors should conduct independent research before deciding.

When is Europlasma’s next earnings report?

Europlasma announced earnings on October 29, 2025. This report provides critical insight into stabilization or deterioration. Investors should monitor closely for turnaround signals.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)